Glaum S R, Proudfit H K, Anderson E G
Department of Pharmacology, University of Illinois, Chicago 60612.
Neurosci Lett. 1988 Dec 19;95(1-3):313-7. doi: 10.1016/0304-3940(88)90677-5.
The ability of the highly selective 5-HT3 receptor antagonist ICS 205-930 (3 alpha-tropanyl-1H-indole-3-carboxylic acid ester) to block the increase in tail flick (TFL) and hot plate latencies (HPL) produced by intrathecally (i.t.) administered serotonin (5-HT) was examined in pargyline pretreated rats. ICS 205-930 (0.1 microgram, i.t.) blocked the ability of 5-HT (200 micrograms) to increase TFL and HPL. Significant hyperalgesia, as measured by a decrease in TFL and HPL compared to saline controls, also resulted from either the coadministration of ICS 205-930 (10 micrograms) and 5-HT (200 micrograms) or from ICS 205-930 (100 micrograms) alone. These data suggest an important role for 5-HT3 receptors in modulating spinal nociceptive responses.
在帕吉林预处理的大鼠中,研究了高选择性5-羟色胺3(5-HT3)受体拮抗剂ICS 205-930(3α-托烷-1H-吲哚-3-羧酸酯)阻断鞘内注射5-羟色胺(5-HT)引起的甩尾潜伏期(TFL)和热板潜伏期(HPL)增加的能力。ICS 205-930(0.1微克,鞘内注射)阻断了5-HT(200微克)增加TFL和HPL的能力。与生理盐水对照组相比,TFL和HPL降低所测得的显著痛觉过敏,也可由ICS 205-930(10微克)和5-HT(200微克)共同给药或单独使用ICS 205-930(100微克)引起。这些数据表明5-HT3受体在调节脊髓伤害性反应中起重要作用。